Chemist + Druggist is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


GPhC records first surplus 'in several years' for 2019-20

The General Pharmaceutical Council (GPhC) has reported a small excess of £300,000 for the 2019-20 financial year, the first such surplus “in several years”, it has announced.

The surplus “is a positive step towards… a financially stable organisation that can effectively fund the cost of regulation”, the GPhC said in its most recent council meeting papers, published ahead of its meeting tomorrow (September 17).

Among the reasons for the underspend were fewer fitness to practise hearing days, as well as fewer training or accreditation events taking place, the GPhC said.

The regulator also cited a reduction in legal costs due to fewer cases being sent to law firm panels and contained IT costs as a result of carrying out more work internally, plus savings due to a “move to cloud-based services”.

Expected surplus

The GPhC also forecast a surplus of £300,000 for its 2020-21 budget as a result of a projected income fall of £500,000, which it estimated would be offset by a £800,000 drop in expenditure after interest and tax.

Due to the "unprecedented impact” of COVID-19 lockdown and restrictions, the GPhC has had to reduce, cancel or postpone “several operational activities” according to the council papers. This has affected income and expenditure and is the key factor behind the predicted surplus, the regulator said.

The GPhC reported a small reduction in income between June-April this year, which it said was “predominantly due” to its decision to postpone the June registration exam due to COVID-19 restrictions.

On March 26, the GPhC and the Pharmaceutical Society of Northern Ireland announced their decision to postpone the 2020 registration assessments due to COVID-19. The GPhC’s registration assessment will take place online towards the end of this year or early in 2021, the regulator said at the time of the announcement.

On March 17, the GPhC stopped all routine inspections due to COVID-19, although intelligence-led inspections to assess any perceived risks to patient safety continued.

What do you make of the GPhC's reported surplus?

Related Content


Pharmacy Dispenser/ Technician
Bethnal Green North, London
Salary: Up to £30,000

Apply Now



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts